Viewing Study NCT02563561


Ignite Creation Date: 2025-12-24 @ 12:09 PM
Ignite Modification Date: 2026-01-18 @ 4:06 PM
Study NCT ID: NCT02563561
Status: TERMINATED
Last Update Posted: 2021-10-27
First Post: 2015-09-21
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: A Study of Intravesical Apaziquone as a Surgical Adjuvant in Participant Undergoing Transurethral Resection Bladder Tumor (TURBT)
Sponsor: Spectrum Pharmaceuticals, Inc
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Bladder Cancer View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Bladder Cancer View
None Non-muscle invasive bladder cancer View
None Apaziquone View
None TURBT View
None Stage Ta, G1-G2 View